miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy

  • Animesh Bhattacharya*
  • , Ulf Schmitz
  • , Yvonne Raatz
  • , Madeleine Schönherr
  • , Tina Kottek
  • , Marianne Schauer
  • , Sandra Franz
  • , Anja Saalbach
  • , Ulf Anderegg
  • , Olaf Wolkenhauer
  • , Dirk Schadendorf
  • , Jan C. Simon
  • , Thomas Magin
  • , Julio Vera
  • , Manfred Kunz
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

84 Scopus citations

Abstract

The present study identified miR-638 as one of the most significantly overexpressed miRNAs in metastatic lesions of melanomas compared with primary melanomas. miR-638 enhanced the tumorigenic properties of melanoma cells in vitro and lung colonization in vivo. mRNA expression profiling identified new candidate genes including TP53INP2 as miR-638 targets, the majority of which are involved in p53 signalling. Overexpression of TP53INP2 severely attenuated proliferative and invasive capacity of melanoma cells which was reversed by miR-638. Depletion of miR-638 stimulated expression of p53 and p53 downstream target genes and induced apoptosis and autophagy. miR-638 promoter analysis identified the miR- 638 target transcription factor associated protein 2a (TFAP2A/AP-2a) as a direct negative regulator of miR-638, suggestive for a double-negative regulatory feedback loop. Taken together, miR-638 supports melanoma progression and suppresses p53-mediated apoptosis pathways, autophagy and expression of the transcriptional repressor TFAP2A/AP-2a.

Original languageEnglish
Pages (from-to)2966-2980
Number of pages15
JournalOncotarget
Volume6
Issue number5
DOIs
StatePublished - 2015
Externally publishedYes

Keywords

  • Apoptosis
  • Melanoma
  • Metastasis
  • MicroRNA
  • p53 pathway

Fingerprint

Dive into the research topics of 'miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy'. Together they form a unique fingerprint.

Cite this